Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.34
+0.17 (2.37%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.16 billion as of April 17, 2025. Its market cap has decreased by -7.44% in one year.
Market Cap
1.16B
Enterprise Value
846.13M
1-Year Change
-7.44%
Ranking
Category
Stock Price
$7.34
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.16B, an increase of 329.74%. That is a compound annual growth rate of 14.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 1.16B | -13.41% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.22B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.41B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |